← FDA DRUG APPROVALS

FDA ANDA · ANDA040224

CHLORPROMAZINE HYDROCHLORIDE

Sponsor: PHARM ASSOC

APPLICATION
ANDA040224
TYPE
ANDA
ORIGINAL APPROVAL
1999-01-26
LATEST ACTION
1999-01-26
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Discontinued

Products

CHLORPROMAZINE HYDROCHLORIDEDiscontinued
CHLORPROMAZINE HYDROCHLORIDE 100MG/ML · CONCENTRATE · ORAL

Approval history

1999-01-26OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →